December 23, 2024 10:12 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait | Jaipur gas tanker crash: Toll touches 14, 30 critical | Arrest warrant against former cricketer Robin Uthappa over 'PF fraud' | PM Modi emplanes for a visit to Kuwait | German Christmas market car attack leaves 2 dead, Saudi Arabian doctor arrested | India, France come together to build world's largest museum in Delhi's Raisina Hill | Canada, US presented no evidence of Indians' involvement in purported criminal acts: Centre informs Parliament amid 'serious allegations' | Delhi Police Crime Branch to investigate FIR against Rahul Gandhi over Parliament tussle
Optimus receives tentative approval from US FDA for generic Brexpiprazole tablets

Optimus receives tentative approval from US FDA for generic Brexpiprazole tablets

Oct 10, 2021, at 03:39 am

Hyderabad/UNI: Optimus Pharma Private Limited Saturday announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for the generic equivalent of Rexulti Tablets in the strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg of Otsuka Pharmaceutical Co. Ltd.